G. Piras et al., ACTION OF URACIL ANALOGS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 539-541
Three structural analogs of 5-ethyl-1-benzyloxymethyl-6-(phenylthio) (
E-BPU) inhibited human immunodeficiency virus type 1 (HIV-1) replicati
on without cytotoxicity in vitro and were more potent than azidothymid
ine and were as potent as E-BPU, The target of these compounds is HIV-
1 reverse transcriptase. Reverse transcriptases resistant to nevirapin
e (tyrosine at position 181 to cysteine) and TIBO R82150 (leucine at p
osition 100 to isoleucine) are cross resistant to E-BPU analogs. Nevir
apine- or TIBO R82150-resistant HIV-1 were cross resistant to E-BPU an
alogs but were inhibited at concentrations 11- to 135-fold lower than
the cytotoxic doses.